EVESOR: a Phase 1 Trial of Everolimus and Sorafenib

Clinical trial NCT01932177 · UNKNOWN

Trial details

NCT number: NCT01932177
Sponsor: Hospices Civils de Lyon
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic or Locally Advanced Solid Tumors

Start date: 2013-04-01
Primary completion: 2013-05-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.